DAVID MARKS: Open Payments
NPI 1760499933 · CHAPEL HILL, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,998 in 111 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $45 · 2025 $1,998
Food & beverage: $1,998
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $500 |
| ABBVIE INC. | 22 | $294 |
| Teva Pharmaceuticals USA, Inc. | 23 | $216 |
| Vanda Pharmaceuticals Inc. | 7 | $173 |
| Janssen Pharmaceuticals, Inc | 6 | $138 |
| PFIZER INC. | 5 | $117 |
| Otsuka America Pharmaceutical, Inc. | 5 | $93 |
| E.R. Squibb & Sons, L.L.C. | 4 | $79 |
| Collegium Pharmaceutical, Inc. | 3 | $58 |
| Lundbeck LLC | 3 | $52 |
Products named: CAPLYTA, VRAYLAR, HETLIOZ, SPRAVATO, AUSTEDO XR, REXULTI, NURTEC ODT, UZEDY.
Industry payments across NC — which companies pay providers there.
